Indeed, NRF2 was proven to be responsible for the radio- and chemoresistance of cancer cells (mainly by stimulating drug metabolism or drug efflux) in addition to inflammation-induced carcinogenesis [11,12]. Here, NFE2L2 is linked to cancer.